Ke Cheng joined North Carolina State University in August 2013 as a Chancellor’s Faculty Excellence Program cluster hire in Translational Regenerative Medicine. He is an Associate Professor in the Department of Molecular Biomedical Sciences at the College of Veterinary Medicine and an Associate Professor in the UNC/NCSU joint Department of Biomedical Engineering. Cheng focuses on the translational aspects of patient-derived stem cells, and interacts frequently with clinicians at the College of Veterinary Medicine to identify needs and develop clinical projects at the Veterinary Health Complex.
Prior to this position, Ke Cheng was an Assistant Professor at Cedars-Sinai Medical Center and University of California Los Angeles School of Medicine, where his research focused on stem cells and regenerative medicine in animal models. Cheng also served as the director of the stem cell lab for multiple clinical trials, including the world's first human trial using cardiac stem cells. Cheng's research has been summarized in rigorous scientific journals including Lancet, Circulation, Circulation Research, Journal of the American College of Cardiology, Stem Cells, Biomaterials, and Cardiovascular Research. He is an Assistant Editor for the Journal of Cellular and Molecular Medicine and serves on the editorial board for several other journals. Cheng’s formal education began with a B.S. in Pharmaceutical Engineering from the Zhejiang University, followed by a Ph.D. degree in Biological Engineering from University of Georgia.